Heligenics develops a technology showing the genetic mutation impact to transform genetic testing and drug development for major diseases.
Business Model:
Revenue: $2M
Employees: 1-10
Address: 833 Las Vegas Blvd N
City: Las Vegas
State: NV
Zip: 89101
Country: US
Heligenics is a life science company that develops a technology showing the genetic mutation impact to transform genetic testing and drug development for major diseases. It measures the significance of mutations in the human genome through a parallel in-vitro process called the GigaAssay, measuring the impact of all potential amino acid substitutions in the functional target protein, doing in a few months what would take many years to do it at all. For cancer diagnostics companies, Heligenics&s; functional data enables improved genetic test interpretation, and for pharmaceutical companies, it empowers the conversion of generic drugs into targeted precision medicines or can rescue a failed drug candidate through the identification of variants for a redesigned genetically-stratified clinical trial. The Las Vegas, Nevada-headquartered company was established by Martin Schiller in 2017.
Contact Phone:
+14157943403
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2020 | Venture Round | $1.2M | 6/2022 | Equity | $2.2M | 8/2022 | Venture Round | $2.2M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|